Detalhe da pesquisa
1.
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Br J Cancer
; 128(2): 266-274, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396818
2.
The Impact of COVID-19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center in Italy.
Oncologist
; 28(12): e1179-e1184, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37699107
3.
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
Breast J
; 26(7): 1296-1301, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31837103
4.
Immune characterization of breast cancer metastases: prognostic implications.
Breast Cancer Res
; 20(1): 62, 2018 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29929548
5.
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Br J Cancer
; 128(2): 398, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460777
6.
Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome.
J Neurooncol
; 131(2): 369-376, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27853958
7.
Complete response to weekly carboplatin-docetaxel chemotherapy in a 91-year-old woman with anaplastic thyroid cancer.
Am J Otolaryngol
; 36(2): 268-72, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25681954
8.
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.
NPJ Breast Cancer
; 9(1): 27, 2023 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37069173
9.
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.
Ther Adv Med Oncol
; 15: 17588359231204857, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38130467
10.
Late onset (22 years) of simultaneous tonsillar and cervical lymph node metastases from breast ductal carcinoma.
Am J Otolaryngol
; 33(5): 627-30, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22483195
11.
Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach.
Crit Rev Oncol Hematol
; 180: 103848, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36257536
12.
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial.
EBioMedicine
; 85: 104320, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36374768
13.
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy.
NPJ Breast Cancer
; 7(1): 101, 2021 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341356
14.
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial.
Eur J Cancer
; 154: 21-29, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34225066
15.
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).
Clin Cancer Res
; 27(12): 3443-3455, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785482
16.
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
Eur J Cancer
; 136: 7-15, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622323
17.
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
ESMO Open
; 5(5): e000843, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33020219
18.
Patterns of Fertility Preservation and Pregnancy Outcome After Breast Cancer at a Large Comprehensive Cancer Center.
J Womens Health (Larchmt)
; 28(4): 544-550, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29963941
19.
Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III Disease.
Front Oncol
; 9: 452, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31245286
20.
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival.
Oncotarget
; 6(39): 42130-49, 2015 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26517523